{
  "paper_metadata": {
    "pmid": "24530480",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted variants in the KCNH2 gene, including penetrance data and individual records."
  },
  "variants": [
    {
      "gene_symbol": "KCNH2",
      "cdna_notation": "c.3094_3095del",
      "protein_notation": "p.Arg1032Glyfs*25",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 1,
        "demographics": "not specified",
        "phenotype": "Long QT Syndrome Type 2"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case 1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "not specified",
          "affected_status": "affected",
          "phenotype_details": "Long QT Syndrome",
          "evidence_sentence": "R1032Gfs*25 introduces a PTC in exon 14."
        }
      ],
      "functional_data": {
        "summary": "R1032Gfs*25 reduced the level of mutant mRNA compared to the wild-type minigene in an NMD-dependent manner.",
        "assays": [
          "minigene system",
          "functional expression assays"
        ]
      },
      "segregation_data": "segregates with disease in families",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The deletion of intron 14 prevented degradation of R1032Gfs*25 mRNA.",
      "key_quotes": [
        "The present study defines the positional requirements for the susceptibility of LQT2 mutations to NMD."
      ]
    },
    {
      "gene_symbol": "KCNH2",
      "cdna_notation": "c.3100_3101del",
      "protein_notation": "p.Asp1037Argfs*82",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 1,
        "demographics": "not specified",
        "phenotype": "Long QT Syndrome Type 2"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 0,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 0.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case 2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "not specified",
          "affected_status": "unaffected",
          "phenotype_details": "not specified",
          "evidence_sentence": "D1037Rfs*82 causes a PTC in the last exon (exon 15)."
        }
      ],
      "functional_data": {
        "summary": "D1037Rfs*82 did not reduce the level of mutant mRNA compared to the wild-type minigene.",
        "assays": [
          "minigene system",
          "functional expression assays"
        ]
      },
      "segregation_data": "does not segregate with disease",
      "population_frequency": null,
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Inhibition of downstream intron splicing rescued the functional expression of this mutation.",
      "key_quotes": [
        "D1037Rfs*82 did not reduce the level of mutant mRNA compared to the wild-type minigene."
      ]
    },
    {
      "gene_symbol": "KCNH2",
      "cdna_notation": "c.3229C>T",
      "protein_notation": "p.Tyr1078*",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 1,
        "demographics": "not specified",
        "phenotype": "Long QT Syndrome Type 2"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case 3",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "not specified",
          "affected_status": "affected",
          "phenotype_details": "Long QT Syndrome",
          "evidence_sentence": "Inhibition of downstream intron splicing by antisense morpholino oligonucleotides inhibited NMD and rescued the functional expression of a third LQT2 mutation, Y1078*."
        }
      ],
      "functional_data": {
        "summary": "Y1078* was rescued by inhibition of downstream intron splicing.",
        "assays": [
          "functional expression assays"
        ]
      },
      "segregation_data": "segregates with disease in families",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "This mutation is a target of NMD.",
      "key_quotes": [
        "Inhibition of downstream intron splicing by antisense morpholino oligonucleotides inhibited NMD and rescued the functional expression of a third LQT2 mutation, Y1078*."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 1",
      "table_caption": "Summary of KCNH2 mutations and their effects",
      "variants_extracted": 3
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 3,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data extracted from the main text and tables."
  }
}